HHS Awards $4.78M for Cepheid Lab Supplies to Cepheid, Undermining Competition
Contract Overview
Contract Amount: $4,780 ($4.8K)
Contractor: Cepheid
Awarding Agency: Department of Health and Human Services
Start Date: 2026-04-08
End Date: 2026-05-29
Contract Duration: 51 days
Daily Burn Rate: $94/day
Competition Type: NOT COMPETED
Pricing Type: FIRM FIXED PRICE
Sector: Healthcare
Official Description: CEPHEID LAB SUPPLIES - WSSU
Place of Performance
Location: WARM SPRINGS, JEFFERSON County, OREGON, 97761
State: Oregon Government Spending
Plain-Language Summary
Department of Health and Human Services obligated $4,780 to CEPHEID for work described as: CEPHEID LAB SUPPLIES - WSSU Key points: 1. Significant award to a single vendor for essential lab supplies. 2. Lack of competition raises concerns about potential overpricing and limited innovation. 3. The Indian Health Service relies on these supplies for critical analytical functions. 4. The contract's short duration suggests a potential for future competitive re-evaluation.
Value Assessment
Rating: questionable
The award of $4.78 million to Cepheid for lab supplies lacks a clear benchmark for value. Without competitive bidding, it's difficult to assess if this price is fair compared to market rates for similar analytical instruments and consumables.
Cost Per Unit: N/A
Competition Analysis
Competition Level: sole-source
This contract was not competed, indicating a sole-source or limited competition approach. This significantly limits price discovery and may lead to higher costs for taxpayers as the vendor faces no pressure to offer competitive pricing.
Taxpayer Impact: The lack of competition in this $4.78 million award means taxpayers may be paying a premium for essential laboratory supplies, as there was no market pressure to secure the best possible price.
Public Impact
Ensures continued operation of analytical laboratories within the Indian Health Service. Potential for increased healthcare costs due to non-competitive award. Impacts the availability and cost of diagnostic testing for specific populations.
Waste & Efficiency Indicators
Waste Risk Score: 94 / 10
Warning Flags
- Lack of competition
- Potential for overpricing
- Sole-source award
Positive Signals
- Essential supplies for healthcare operations
- Clear end date for the contract
Sector Analysis
The healthcare sector, particularly analytical laboratory instrument manufacturing, often involves specialized equipment. While some components might be proprietary, a lack of competition for consumables or routine supplies warrants scrutiny to ensure cost-effectiveness.
Small Business Impact
This award does not appear to include provisions for small business participation. The sole-source nature of the contract likely precluded opportunities for small businesses to compete for this significant portion of federal spending.
Oversight & Accountability
The non-competed nature of this award raises questions about the oversight processes within the Indian Health Service. A review of the justification for sole-source procurement is warranted to ensure adherence to federal acquisition regulations.
Related Government Programs
- Analytical Laboratory Instrument Manufacturing
- Department of Health and Human Services Contracting
- Indian Health Service Programs
Risk Flags
- Lack of competition
- Potential for inflated pricing
- Sole-source justification unclear
- Limited small business opportunity
Tags
analytical-laboratory-instrument-manufac, department-of-health-and-human-services, or, delivery-order, under-100k
Frequently Asked Questions
What is this federal contract paying for?
Department of Health and Human Services awarded $4,780 to CEPHEID. CEPHEID LAB SUPPLIES - WSSU
Who is the contractor on this award?
The obligated recipient is CEPHEID.
Which agency awarded this contract?
Awarding agency: Department of Health and Human Services (Indian Health Service).
What is the total obligated amount?
The obligated amount is $4,780.
What is the period of performance?
Start: 2026-04-08. End: 2026-05-29.
What is the justification for awarding this contract on a sole-source basis, and were alternative competitive strategies considered?
The provided data indicates the contract was 'NOT COMPETED'. A thorough review would require access to the contract file to understand the specific justification (e.g., urgent need, unique capability). Without this, it's impossible to definitively assess if alternative competitive strategies were explored or if a sole-source award was truly the only viable option to meet the government's requirements.
How does the $4.78 million price compare to market benchmarks for similar analytical laboratory instruments and supplies?
Without access to detailed pricing breakdowns and market analysis conducted by the agency, a direct comparison is difficult. However, the absence of competition inherently suggests the price may not be optimized. Benchmarking would involve comparing unit costs for reagents, consumables, and instrument maintenance against similar contracts or commercial price lists from other vendors.
What is the potential impact of this sole-source award on the long-term availability and cost-effectiveness of critical laboratory services for the Indian Health Service?
A sole-source award can lead to vendor lock-in, potentially increasing costs over time as competition is absent. This could strain the budget for critical laboratory services. Future competitive procurements, if pursued, would be essential to ensure sustained cost-effectiveness and potentially introduce newer, more efficient technologies.
Industry Classification
NAICS: Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Analytical Laboratory Instrument Manufacturing
Product/Service Code: INSTRUMENTS AND LABORATORY EQPT
Competition & Pricing
Extent Competed: NOT COMPETED
Solicitation Procedures: ONLY ONE SOURCE
Pricing Type: FIRM FIXED PRICE (J)
Evaluated Preference: NONE
Contractor Details
Parent Company: Danaher Corporation
Address: 904, EAST CARIBBEAN DRIVE, SUNNYVALE, CA, 94089
Business Categories: Category Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Not Designated a Small Business, Special Designations, U.S.-Owned Business
Financial Breakdown
Contract Ceiling: $4,780
Exercised Options: $4,780
Current Obligation: $4,780
Contract Characteristics
Commercial Item: COMMERCIAL PRODUCTS/SERVICES
Cost or Pricing Data: NO
Parent Contract
Parent Award PIID: 75H71322D00001
IDV Type: IDC
Timeline
Start Date: 2026-04-08
Current End Date: 2026-05-29
Potential End Date: 2026-05-29 00:00:00
Last Modified: 2026-04-08
More Contracts from Cepheid
- 8508994567!xpert Xpress Sars-Cov-2/Flu/R — $340.0M (Department of Defense)
- Covid 19 FLU Test Kits and Swabs — $146.3M (Department of Veterans Affairs)
- OTA - Pandemic Preparedness and Response: Establishing a Platform for Diagnosis and Surveillance of Emerging Threats — $75.0M (Department of Health and Human Services)
- Covid-19 Dhhs Industrial Base Expansion for Test Kits — $59.7M (Department of Defense)
- Contractor Shall Provide VA With Emergency Covid-19 Molecular Test Kits — $52.5M (Department of Veterans Affairs)
Other Department of Health and Human Services Contracts
- Contact Center Operations (CCO) — $5.5B (Maximus Federal Services, Inc.)
- TAS::75 0849::TAS Oper of Govt R&D Goco Facilities — $4.8B (Leidos Biomedical Research Inc)
- THE Purpose of This Contract IS to Provide the Full Complement of Services Necessary to Care for UC in ORR Custody Including Facilities Set-Up, Maintenance, and Support Internal and Perimeter (IF Applicable) Security, Direct Care and Supervision Inc — $3.5B (Rapid Deployment Inc)
- Contact Center Operations — $2.6B (Maximus Federal Services, Inc.)
- Federal Contract — $2.4B (Leidos Biomedical Research Inc)
View all Department of Health and Human Services contracts →